Guidelines – Policy & Medicine

Stakeholders Provide Feedback on FDA Misinformation Draft Guidance

United States Agencies Release New Final Rules Implementing the MHPAEA

New Advertising Rules for Human Prescription Drugs Now in Effect

ACA Section 1557: A Comprehensive Overview for Healthcare Providers

Changes to 340B Program Finalized

ONC Issues Final Rule on Health Data Technology Updates

FDA Issues Guidance Documents to Streamline Premarket Review and Approval Process

ONC Finalizes Changes to Information Blocking Rules

FDA Releases Finalized Guidance on Use of Real-World Data in New Drug and Biological Product Submissions

Pharmaceutical Industry Pushes Back on Draft Guidance Issued by FDA Over SIUU